Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Tuberous Sclerosis 1 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Epilepsy 1 Cut-Off Value 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Breast Cancer Lymphedema 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Carboplatin 330 Pemetrexed 266 Cisplatin 234 Docetaxel 195 Paclitaxel 182 Radiotherapy 181 Erlotinib Hydrochloride 153 pembrolizumab 147 Gemcitabine 147 Bevacizumab 125 Drug Therapy 121 Radiosurgery 115 Nivolumab 112 osimertinib 92 durvalumab 88 Gefitinib 67 atezolizumab 63 Vinorelbine 63 Surgical Procedures, Operative 62 Magnetic Resonance Spectroscopy 54 anlotinib 42 Immunotherapy 42 Taxes 39 Blood Specimen Collection 39 Ipilimumab 38 130-nm albumin-bound paclitaxel 38 Specimen Handling 36 Immune Checkpoint Inhibitors 35 Radiation 34 Albumin-Bound Paclitaxel 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Non-Small-Cell Lung × Fluid Therapy × Clear all

NCT02894853 2017-09-14

LEMA

The Netherlands Cancer Institute

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡